loading page

Mycophenolate Mofetil-Induced Peripheral Neuropathy In The Treatment of Membranous Glomerulonephropathy: A Case Report
  • Minoo Moghimi,
  • Zahra Nekoukar,
  • ّFarhad Gholami
Minoo Moghimi
Mazandaran University of Medical Sciences
Author Profile
Zahra Nekoukar
Mazandaran University of Medical Sciences
Author Profile
ّFarhad Gholami
Mazandaran University of Medical Sciences
Author Profile

Abstract

Mycophenolate mofetil (MMF) as an immunosuppressive agent is widely used in the management of Membranous Glomerulonephropathy (MGN). In this report, we describe a 66-year-old male MGN case treated with MMF and revealed acquired sensory-motor axonal polyneuropathy, which is rare and has not been reported before.

Peer review status:UNDER REVIEW

23 Jan 2021Submitted to Clinical Case Reports
07 Apr 2021Assigned to Editor
07 Apr 2021Submission Checks Completed
28 Apr 2021Reviewer(s) Assigned